← Back to Search

SNOO users for Sudden Infant Death Syndrome

N/A
Recruiting
Led By Christopher Laine, PhD
Research Sponsored by Happiest Baby, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up when infant was 0-6 months old (and still using snoo)
Awards & highlights

Study Summary

This postmarket surveillance study will evaluate the safety of the SNOO Smart Sleeper Bassinet when used for infants who are at high risk for Sudden Unexpected Infant Death (SUID). This study will survey 1000 caregivers of high-risk infants to examine the frequency of death or serious injury occurring in the SNOO Bassinet.

Eligible Conditions
  • Sudden Infant Death Syndrome
  • Serious Injury

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~when infant was 0-6 months old (and still using snoo)
This trial's timeline: 3 weeks for screening, Varies for treatment, and when infant was 0-6 months old (and still using snoo) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Infant death
Serious Injury
Secondary outcome measures
Degree of SNOO use
Infant age during SNOO use
Weaning rationale

Trial Design

1Treatment groups
Experimental Treatment
Group I: SNOO usersExperimental Treatment1 Intervention
Caregivers who use the SNOO Bassinet with their infant and who meet eligibility criteria

Find a Location

Who is running the clinical trial?

Happiest Baby, Inc.Lead Sponsor
2 Previous Clinical Trials
160 Total Patients Enrolled
Christopher Laine, PhDPrincipal InvestigatorHappiest Baby, Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~667 spots leftby Sep 2025